<oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd"><dc:title>Elevated Fecal Calprotectin in the Second or Third Trimester of Pregnancy Predicts Preterm Delivery in Women with IBD</dc:title><dc:identifier>https://doi.org/10.7939/DVN/10902</dc:identifier><dc:creator>Huang, Vivian</dc:creator><dc:creator>Elahi, Shokrollah</dc:creator><dc:creator>Madsen, Karen</dc:creator><dc:creator>Fedorak, Richard</dc:creator><dc:creator>Dieleman, Levinus</dc:creator><dc:creator>Wine, Eytan</dc:creator><dc:creator>Lumb, Rowan</dc:creator><dc:publisher>UAL Dataverse</dc:publisher><dc:description>The objective of this study was to evaluate whether a FCP measurement in the 2nd or 3rd trimester of pregnancy in women with IBD can predict preterm delivery.</dc:description><dc:subject>Medicine, Health and Life Sciences</dc:subject><dc:subject>Crohn's disease</dc:subject><dc:subject>pregnancy</dc:subject><dc:subject>ulcerative colitis</dc:subject><dc:subject>cohort studies</dc:subject><dc:subject>infant</dc:subject><dc:subject>biomarkers</dc:subject><dc:subject>C-reactive protein</dc:subject><dc:subject>inflammatory bowel diseases</dc:subject><dc:subject>faecal calprotectin</dc:subject><dc:date>2015</dc:date><dc:relation>Effects of Maternal IBD and IBD Breast Milk on Neonatal Gut Microbiome and Intestinal Inflammation</dc:relation><dc:relation>Immunological Profiling</dc:relation><dc:type>Clinical data; Biosamples</dc:type></oai_dc:dc>